Search details
1.
Targeting the immune microenvironment in Waldenström macroglobulinemia via halting the CD40/CD40-ligand axis.
Blood
; 141(21): 2615-2628, 2023 05 25.
Article
in English
| MEDLINE | ID: mdl-36735903
2.
Minimal residual disease-driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL.
Blood
; 140(22): 2348-2357, 2022 12 01.
Article
in English
| MEDLINE | ID: mdl-35921541
3.
Halting the FGF/FGFR axis leads to antitumor activity in Waldenström macroglobulinemia by silencing MYD88.
Blood
; 137(18): 2495-2508, 2021 05 06.
Article
in English
| MEDLINE | ID: mdl-33197938
4.
A randomized phase 3 trial of zanubrutinib vs ibrutinib in symptomatic Waldenström macroglobulinemia: the ASPEN study.
Blood
; 136(18): 2038-2050, 2020 10 29.
Article
in English
| MEDLINE | ID: mdl-32731259
5.
Clinical characteristics and risk factors for mortality in hematologic patients affected by COVID-19.
Cancer
; 126(23): 5069-5076, 2020 12 01.
Article
in English
| MEDLINE | ID: mdl-32910456
6.
Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.
Haematologica
; 105(2): 448-456, 2020.
Article
in English
| MEDLINE | ID: mdl-31371416
7.
Younger patients with Waldenström Macroglobulinemia exhibit low risk profile and excellent outcomes in the era of immunotherapy and targeted therapies.
Am J Hematol
; 95(12): 1473-1478, 2020 12.
Article
in English
| MEDLINE | ID: mdl-32780514
8.
Long-term benefit of IGHV mutated patients in a real-life multicenter cohort of FCR-treated chronic lymphocytic leukemia.
Hematol Oncol
; 41(3): 567-570, 2023 08.
Article
in English
| MEDLINE | ID: mdl-36190298
9.
Molecular prediction of durable remission after first-line fludarabine-cyclophosphamide-rituximab in chronic lymphocytic leukemia.
Blood
; 126(16): 1921-4, 2015 Oct 15.
Article
in English
| MEDLINE | ID: mdl-26276669
10.
Risk of hepatitis B virus reactivation in chronic lymphocytic leukemia patients receiving ibrutinib with or without antiviral prophylaxis. A retrospective multicentric GIMEMA study.
Haematologica
; 107(6): 1470-1473, 2022 06 01.
Article
in English
| MEDLINE | ID: mdl-35199505
11.
Factors predicting survival in chronic lymphocytic leukemia patients developing Richter syndrome transformation into Hodgkin lymphoma.
Am J Hematol
; 92(6): 529-535, 2017 Jun.
Article
in English
| MEDLINE | ID: mdl-28295527
12.
Management of chronic lymphocytic leukemia in Italy during a one year of the COVID-19 pandemic and at the start of the vaccination program. A Campus CLL report.
Hematol Oncol
; 39(4): 570-574, 2021 Oct.
Article
in English
| MEDLINE | ID: mdl-34258787
13.
Biomarker analysis of the ASPEN study comparing zanubrutinib with ibrutinib for patients with Waldenström macroglobulinemia.
Blood Adv
; 8(7): 1639-1650, 2024 Apr 09.
Article
in English
| MEDLINE | ID: mdl-38315878
14.
Anorectal Function and Clinical Characteristics Associated with Faecal Incontinence in Patients with Crohn's Disease.
J Crohns Colitis
; 17(8): 1252-1261, 2023 Aug 21.
Article
in English
| MEDLINE | ID: mdl-36951290
15.
Zanubrutinib Versus Ibrutinib in Symptomatic Waldenström Macroglobulinemia: Final Analysis From the Randomized Phase III ASPEN Study.
J Clin Oncol
; 41(33): 5099-5106, 2023 Nov 20.
Article
in English
| MEDLINE | ID: mdl-37478390
16.
Causes of renal failure in patients with decompensated cirrhosis and its impact in hospital mortality.
Ann Hepatol
; 11(1): 90-5, 2012.
Article
in English
| MEDLINE | ID: mdl-22166566
17.
Variables associated with progression of moderate-to-severe Crohn's disease.
BMJ Open Gastroenterol
; 9(1)2022 11.
Article
in English
| MEDLINE | ID: mdl-36379617
18.
Direct-Acting Antivirals as Primary Treatment for Hepatitis C Virus-Associated Indolent Non-Hodgkin Lymphomas: The BArT Study of the Fondazione Italiana Linfomi.
J Clin Oncol
; 40(35): 4060-4070, 2022 12 10.
Article
in English
| MEDLINE | ID: mdl-35714311
19.
Long-term follow-up of cladribine treatment in hairy cell leukemia: 30-year experience in a multicentric Italian study.
Blood Cancer J
; 12(7): 109, 2022 07 19.
Article
in English
| MEDLINE | ID: mdl-35853850
20.
Preneoplastic somatic mutations including MYD88L265P in lymphoplasmacytic lymphoma.
Sci Adv
; 8(3): eabl4644, 2022 01 21.
Article
in English
| MEDLINE | ID: mdl-35044826